Interested in infectious disease litigation? Before you accept a case, read this
When Davis M. Walsh and Samuel L. Tarry began assembling Infectious Disease Litigation: Science, Law, and Procedure, they had no idea a pandemic was soon going to make the topic more relevant than ever.
In this new episode of the Modern Law Library podcast, Walsh and Tarry talk to the ABA Journal’s Lee Rawles about the experience of editing the book, the unique challenges of litigating infectious disease cases, their advice for attorneys looking to get into the expanding field, and how COVID-19 might have changed juries’ points of view in such cases.
While COVID-19 might be at the top of people’s minds, there is much more to infectious disease litigation than that.
Class action lawsuits in the food industry after outbreaks of salmonella or E. coli have brought multimillion-dollar verdicts. Legionnaires’ disease can strike through a faulty air-circulation system in a building.
The editors of this volume bring their expertise to every step of the litigation process, from deciding whether to accept a case to discovery to selecting a jurisdiction and jury.
Apple | Spotify | Google Play
In This Podcast:
Samuel L. Tarry
Samuel L. Tarry is a partner at McGuireWoods, a member of the firm’s trial practice steering committee, and a past chair of the product and consumer litigation department. For nearly three decades, he has represented clients in tort, environmental and public health litigation in state and federal courts across the country. He has won jury trial verdicts in 10 states and successfully managed thousands of cases to resolution. He is an editor of Infectious Disease Litigation: Science, Law, and Procedure.
Davis M. Walsh
Davis M. Walsh is a partner at McGuireWoods who focuses his practice on representing public and private companies, predominantly in the automotive, medical device and transportation sectors, in state and federal court. He is the lead editor of Infectious Disease Litigation: Science, Law, and Procedure.
